Japanese Biotech Fund takes up all Rights Issue Shortfall

Tuesday, 19 November 2019

Regeneus has placed the full shortfall of 9,437,872 shares under its recent Non-Renounceable Rights issue. The shortfall was placed to a Japan-based institutional investor at an issue price of A$0.08 per share for a total of A$755,029. It is expected that the shortfall shares will be issued on 20 November 2019.